期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 668, 期 1-2, 页码 340-346出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2011.06.036
关键词
Glucagon-like peptide-1 receptor; Exendin-4; Exendin (9-39); Central nervous system; Glucose-lowering effect; Suncus murinus
资金
- CUHK [CUHK 2005.1.042]
Glucagon-like peptide-1 (7-36) amide (GLP-1) is released from the gut as an incretin hormone to stimulate glucose-stimulated insulin secretion. GLP-1 is also produced in the central nervous system (CNS) as a neurotransmitter that regulates feeding behaviour. By using polyclonal antiserum against GLP-1 and GLP-1 receptors, we identified the distribution of GLP-1 immunoreactive fibres and GLP-1 receptor immunoreactivity in the ventromedial hypothalamus of Suncus murinus ( house musk shrew). In functional studies, subcutaneous administration of exendin-4 (1 - 30 nmol/kg) reduced blood glucose levels dose-dependently by up to 49% during an intraperitoneal glucose tolerance test (P < 0.001). The glucose-lowering effects were also observed after an intracerebroventricular (i.c.v.; 0.3 - 3 nmol) or intracerebral ventromedial hypothalamic microinfusion (iVMH; 0.3 - 3 pmol) of exendin-4. The area under the curve values for glucose after i.c.v. and iVMH administrations of exendin-4 were reduced by up to 53% ( P < 0.01) and 46% ( P < 0.01), respectively. Exendin-4 ( i.c.v.; 3 nmol) also increased glucose-stimulated insulin secretion by 20% compared to controls (P < 0.05). The GLP-1 receptor antagonist, exendin (9-39) ( 10 nmol, i.c.v.) did not modify blood glucose levels but it antagonized the glucose-lowering effect of exendin-4 ( 1 nmol, i.c.v.; P < 0.05). The data suggests that the central GLP-1 system may regulate glucose homeostasis by increasing insulin secretion. Further, GLP-1 receptors in the ventromedial hypothalamus appear to play an important role in the regulation of glucose homeostasis in S. murinus. (C) 2011 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据